XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.1
Contingent Consideration - Narrative (Details)
$ in Thousands
3 Months Ended
Jun. 09, 2020
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Nov. 24, 2021
right
Business Acquisition [Line Items]        
Fair value of contingent consideration $ 230,000      
Contingent consideration   $ 665 $ 1,020  
Payment of contingent consideration   22,900 $ 0  
SPN-30 Regulatory and Commercial Activities        
Business Acquisition [Line Items]        
Fair value of contingent consideration 130,000      
SPN-830 FDA Acceptance Milestone        
Business Acquisition [Line Items]        
Fair value of contingent consideration 25,000      
SPN-830 NDA Approval Milestone        
Business Acquisition [Line Items]        
Fair value of contingent consideration 105,000      
SPN-830 First Commercial And Sale Milestone        
Business Acquisition [Line Items]        
Fair value of contingent consideration 100,000      
Future Sales Performance        
Business Acquisition [Line Items]        
Fair value of contingent consideration 100,000      
APOKYN        
Business Acquisition [Line Items]        
Fair value of contingent consideration 35,000      
APOKYN and SPN-830        
Business Acquisition [Line Items]        
Fair value of contingent consideration $ 65,000      
USWM Acquisition        
Business Acquisition [Line Items]        
Contingents value rights | right       2
Contingent consideration   $ 700